Aristopharma Ltd. take pride in announcing the launch of a new Dry Powder Inhaler Triflo Arocap

“Triflo Arocap”, a once-daily triple combination of ICS/LAMA/LABA consisting of Fluticasone, Umeclidinium & Vilanterol, the first and only once-daily, 3-in-1 treatment option, approved by USFDA to meet your patients’ necessities and conveniences.  Triflo Arocap is a truly once-daily 3-in-1 medicine, that works combinedly to control Asthma, COPD & ACO. Triflo Arocap ensures excellent lung function improvement in both Asthma & COPD patients compared to LAMA/LABA or ICS/ LABA. Triflo Arocap combination is recommended & approved by various guidelines & regulatory agencies e.g., FDA, EMA, GINA, GOLD, BNF, etc.